Global biotech firm hopes to reduce costs, increase R&D efforts with Ariba ESM solutions
Sunnyvale, CA — April 28, 2004 — Genzyme Corp., a global biotechnology company, said it has selected Ariba Buyer, Ariba Enterprise Sourcing, and services from Ariba's Solutions Delivery (ASD) team to improve management of the company's corporate-wide spend and streamline its procurement processes.
With more than 25 major products and services helping patients in more than 80 countries, Genzyme is developing and applying the most advanced capabilities in biotechnology today to address a range of unmet medical needs. In order to achieve these goals, Genzyme sought a way to reduce operational costs to increase bottom line savings.
After evaluating approximately 20 vendors, Genzyme selected Ariba Buyer and Ariba Enterprise Sourcing as part of a strategic initiative to drive down procurement costs, establish new process efficiencies, automate procurement and sourcing, establish more advantageous pricing, and renegotiate contracts on a global basis.
Genzyme said it plans to roll out Ariba enterprise spend management (ESM) tools in both North America and Europe to automate its sourcing and procurement processes. Genzyme will use ASD team's experience and knowledge of best practices to meet its corporate-wide cost-reduction goals.